Singular Genomics Systems
Stock Forecast, Prediction & Price Target

	Passed			Analyst forecast
Metric	12/31/2021	12/31/2022	12/31/2023	12/31/2025	12/31/2026
Revenue % change YoY	$0 N/A	$765K 0%	$2.91M 280.52%	Avg: $10.99M Low: $10.99M High: $10.99M avg. 277.77%	Avg: $23.23M Low: $23.23M High: $23.23M avg. 111.30%
Net Income % change YoY	$-98.88M N/A	$-88.27M 10.73%	$-94.82M -7.41%	Avg: $-86.78M Low: $-2.57B High: $-2.28B avg. 8.47%	Avg: $-88.78M Low: $-1.79B High: $-1.63B avg. -2.30%
EBITDA % change YoY	$-60.54M N/A	$-90.11M -48.83%	$-86.49M 4.01%	Avg: $2.19M Low: $2.19M High: $2.19M avg. 102.54%	Avg: $4.64M Low: $4.64M High: $4.64M avg. 111.30%
EPS % change YoY	-$1.37 N/A	-$1.24 9.48%	-$39.08 -3051.61%	Avg: -$33.43 Low: -$35.4 High: -$31.45 avg. 14.47%	Avg: -$23.52 Low: -$24.6 High: -$22.43 avg. 29.64%
Operating Expenses % change YoY	$61.27M N/A	$93.46M 52.52%	$102.24M 9.39%	Avg: $183.64M Low: $183.64M High: $183.64M avg. 79.61%	Avg: $388.04M Low: $388.04M High: $388.04M avg. 111.30%

FAQ

Wall Street analysts estimate the annual average earnings growth rate of 3.08% in 2025-2026.

We have gathered data from 2 analysts. Their low estimate is -2.57B, average is -86.78M and high is -2.28B.

Wall Street analysts forecast annual average revenue growth of 194.53% in 2025-2026.

We have gathered data from 1 analysts. Their low revenue estimate is $10.99M, average is $10.99M and high is $10.99M.

Wall Street analysts forecast annual average earnings growth of 22.05% in 2025-2026.

We have gathered data from 2 analysts. Their low earnings per share estimate is -$35.4, average is -$33.43 and high is $-31.45.